Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages
MAR da Costa Santos, JS Dos Reis… - Immunologic …, 2023 - Springer
Macrophage (Mϕ) polarization is an essential phenomenon for the maintenance of
homeostasis and tissue repair, and represents the event by which Mϕ reach divergent …
homeostasis and tissue repair, and represents the event by which Mϕ reach divergent …
Crosstalk between cancer and the neuro-immune system
N Kuol, L Stojanovska, V Apostolopoulos… - Journal of …, 2018 - Elsevier
In the last decade, understanding of cancer initiation and progression has been given much
attention with studies mainly focusing on genetic abnormalities. Importantly, cancer cells can …
attention with studies mainly focusing on genetic abnormalities. Importantly, cancer cells can …
[HTML][HTML] ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion
SP Gnosa, LP Blasco, KB Piotrowski, ML Freiberg… - JCI insight, 2022 - ncbi.nlm.nih.gov
Macrophages in the tumor microenvironment have a substantial impact on tumor
progression. Depending on the signaling environment in the tumor, macrophages can either …
progression. Depending on the signaling environment in the tumor, macrophages can either …
The biological and biomechanical role of transglutaminase-2 in the tumour microenvironment
R Tempest, S Guarnerio, R Maani, J Cooper, N Peake - Cancers, 2021 - mdpi.com
Simple Summary Transglutaminase-2 (TG2) is an enzyme primarily involved in protein cross-
linking, which has been shown to play a role in the development and progression of …
linking, which has been shown to play a role in the development and progression of …
Progress of cell‐derived biomimetic drug delivery systems for cancer therapy
T Lang, Q Yin, Y Li - Advanced Therapeutics, 2018 - Wiley Online Library
Certain types of cells possess unique characteristics such as tumor homing and prolonged
circulation in blood, which are worthy of being exploited in drug delivery carriers for cancer …
circulation in blood, which are worthy of being exploited in drug delivery carriers for cancer …
Phagocyte—extracellular matrix crosstalk empowers tumor development and dissemination
C Varol, I Sagi - The FEBS journal, 2018 - Wiley Online Library
Phagocytes, such as tumor‐associated macrophages (TAM s) and tumor‐associated
neutrophils (TAN s), are abundant in the stroma of experimental and human tumors and are …
neutrophils (TAN s), are abundant in the stroma of experimental and human tumors and are …
The interplay of the extracellular matrix and stromal cells as a drug target in stroma-rich cancers
The tumor microenvironment (TME) is a complex neighborhood that consists of immune
cells, fibroblasts, pericytes, adipocytes, endothelial and neuronal cells, and the extracellular …
cells, fibroblasts, pericytes, adipocytes, endothelial and neuronal cells, and the extracellular …
Immune remodeling of the extracellular matrix drives loss of cancer stem cells and tumor rejection
A Pires, A Greenshields-Watson, E Jones… - Cancer immunology …, 2020 - AACR
The nature of the tumor microenvironment (TME) influences the ability of tumor-specific T
cells to control tumor growth. In this study, we performed an unbiased comparison of the …
cells to control tumor growth. In this study, we performed an unbiased comparison of the …
Stroma as an active player in the development of the tumor microenvironment
L Vannucci - Cancer Microenvironment, 2015 - Springer
The stroma is a considerable part of the tumor microenvironment. Because of its complexity,
it can influence both cancer and immune cells in their behavior and cross-talk. Aside from …
it can influence both cancer and immune cells in their behavior and cross-talk. Aside from …
Trabectedin and plitidepsin: Drugs from the sea that strike the tumor microenvironment
CM Galmarini, M D'Incalci, P Allavena - Marine Drugs, 2014 - mdpi.com
The prevailing paradigm states that cancer cells acquire multiple genetic mutations in
oncogenes or tumor suppressor genes whose respective activation/up-regulation or loss of …
oncogenes or tumor suppressor genes whose respective activation/up-regulation or loss of …